Ning Xie
Fortuna: 26 M $ al 30/09/2026
Fortuna: 26 M $ al 30/09/2026
Ning Xie has a doctorate degree from China Pharmaceutical University and an undergraduate degree from Jiangxi University of Chinese Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/09/2026 | 6.570.000 ( 2,37 % ) | 26 M $ | 30/09/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| MABWELL (SHANGHAI) BIOSCIENCE CO., LTD. | Director/Miembro de la Junta | 01/12/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
China Pharmaceutical University
China Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mabwell (Shanghai) Bioscience Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals for oncology & age related ophthalmology, orthopedics and immunology diseases | Health Technology |
Jiangxi University of Chinese Medicine
Jiangxi University of Chinese Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.